Weekender 4/17/2015

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. The Biotechnology Industry Organization (BIO) announced its selection of Representative Leonard Lance as Legislator of the Year for 2015. BioNJ was proud to nominate the Congressman for this honor, which is so well deserved given his leadership on so many fronts… Read the full article


Weekender 4/10/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. On April 22, BioNJ, BDO, NJEDA, and Tax Transfer Corporation will hold an educational Webinar entitled Don’t Leave Money on the Table! that will provide up-to-date information on important NOL Program changes. The Webinar starts at 10 a.m. and will feature BioNJ President… Read the full article


Weekender 4/3/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. The biotech industry opens the NASDAQ! BioNJ’s President and CEO Debbie Hart joined other biotech colleagues, including Jim Greenwood, President and CEO of BIO; Nathan Tinker, Executive Director of NewYorkBIO and Chris Molineaux, President of Pennsylvania BIO, to officially open trading… Read the full article


Weekender 3/27/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Congratulations to the Coriell Institute for Medical Research in Camden, for its announcement on March 16 that it has won a $14 million grant from the National Institutes of Health to advance the work of the Institute, which maintains a diverse… Read the full article


Weekender 3/13/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Let’s start the good news with another FDA approval in 2015, shall we? Congratulations to Actavis for its approval of AVYCAZ, a treatment for adult patients with complicated intra-abdominal infections and complicated urinary tract infections. This week’s excitement continues with the… Read the full article


Weekender 3/6/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Not even another snowy lead-in to the weekend can stop the good news radiating from our Members like the sun we are all hoping to see very, very soon! Congrats to our Members Bristol-Myers Squibb Company as well as Actavis on… Read the full article


Weekender 2/27/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Congratulations New Jersey on being 100 percent!! Following the success touted at the Annual Dinner Meeting and Innovation Celebration earlier this month, companies with a footprint in New Jersey are responsible for 100 percent of the innovator drugs (NME/BLA) approved by… Read the full article


Weekender 2/20/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Following on the recent Annual Meeting Celebration of Innovators that had recent drug approvals, congratulations to Celgene Corporation for its announcement that the U.S. Food and Drug Administration (FDA) has expanded the existing indication for REVLIMID (lenalidomide) in combination with dexamethasone… Read the full article


Weekender 2/13/15

Welcome to another edition of The Weekender. To all who came out on February 5 to support our 22nd Annual Dinner Meeting and Innovation Celebration, thank you! The event was a tremendous success with over 750 registrants. We hope you enjoyed the plentiful networking and great stories from our keynote speaker The Marathon Man Don… Read the full article


Weekender 1/30/15

Welcome to another edition of The Weekender. We didn’t get to say it last week, so congratulations to the NPS Pharma team and their President and CEO Dr. Francois Nader, who received FDA approval for Natpara! This is NPS’s second drug approval in as many years and excellent news for the New Jersey life sciences… Read the full article